Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2008 2
2009 3
2010 1
2011 1
2012 1
2013 3
2014 3
2015 2
2016 6
2017 7
2018 5
2019 8
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for tianqing chu
Search for Tianxing Chu instead (2 results)
Circulating DNA-Based Sequencing Guided Anlotinib Therapy in Non-Small Cell Lung Cancer.
Lu J, Zhong H, Wu J, Chu T, Zhang L, Li H, Wang Q, Li R, Zhao Y, Gu A, Wang H, Shi C, Xiong L, Zhang X, Zhang W, Lou Y, Yan B, Dong Y, Zhang Y, Li B, Zhang L, Zhao X, Li K, Han B. Lu J, et al. Among authors: chu t. Adv Sci (Weinh). 2019 Aug 19;6(19):1900721. doi: 10.1002/advs.201900721. eCollection 2019 Oct 2. Adv Sci (Weinh). 2019. PMID: 31592412 Free PMC article.
Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy.
Lu J, Zhong H, Chu T, Zhang X, Li R, Sun J, Zhong R, Yang Y, Alam MS, Lou Y, Xu J, Zhang Y, Wu J, Li X, Zhao X, Li K, Lu L, Han B. Lu J, et al. Among authors: chu t. Eur Respir J. 2019 Mar 7;53(3):1801562. doi: 10.1183/13993003.01562-2018. Print 2019 Mar. Eur Respir J. 2019. PMID: 30578392 Free article. Clinical Trial.
Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies.
Qian J, Nie W, Lu J, Zhang L, Zhang Y, Zhang B, Wang S, Hu M, Xu J, Lou Y, Dong Y, Niu Y, Yan B, Zhong R, Zhang W, Chu T, Zhong H, Han B. Qian J, et al. Among authors: chu t. Int J Cancer. 2020 Jun 1;146(11):3124-3133. doi: 10.1002/ijc.32717. Epub 2019 Nov 1. Int J Cancer. 2020. PMID: 31583695
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial.
Han B, Jin B, Chu T, Niu Y, Dong Y, Xu J, Gu A, Zhong H, Wang H, Zhang X, Shi C, Zhang Y, Zhang W, Lou Y, Zhu L, Pei J. Han B, et al. Among authors: chu t. Int J Cancer. 2017 Sep 15;141(6):1249-1256. doi: 10.1002/ijc.30806. Epub 2017 Jun 21. Int J Cancer. 2017. PMID: 28560853 Free article. Clinical Trial.
LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma.
Qian G, Jiang W, Zou B, Feng J, Cheng X, Gu J, Chu T, Niu C, He R, Chu Y, Lu M. Qian G, et al. Among authors: chu t. J Exp Med. 2018 Sep 3;215(9):2397-2412. doi: 10.1084/jem.20172225. Epub 2018 Jul 18. J Exp Med. 2018. PMID: 30021797 Free PMC article.
Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib.
Chen D, Xu J, Zhao Y, Chu T, Zhong H, Han B, Zhong R. Chen D, et al. Among authors: chu t. J Cancer Res Clin Oncol. 2020 Feb;146(2):401-406. doi: 10.1007/s00432-019-03064-1. Epub 2019 Nov 6. J Cancer Res Clin Oncol. 2020. PMID: 31691871
New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer.
Qiang H, Chang Q, Xu J, Qian J, Zhang Y, Lei Y, Han B, Chu T. Qiang H, et al. Among authors: chu t. J Cancer Res Clin Oncol. 2020 Mar;146(3):631-645. doi: 10.1007/s00432-020-03129-6. Epub 2020 Feb 17. J Cancer Res Clin Oncol. 2020. PMID: 32065262 Review.
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China.
Xu J, Jin B, Chu T, Dong X, Yang H, Zhang Y, Wu D, Lou Y, Zhang X, Wang H, Han B. Xu J, et al. Among authors: chu t. Lung Cancer. 2016 Jun;96:87-92. doi: 10.1016/j.lungcan.2016.01.018. Epub 2016 Jan 30. Lung Cancer. 2016. PMID: 27133756
Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review.
Zhang B, Zhang Y, Xu J, Zhang X, Chu T, Wang S, Qian J, Qiao R, Lu J, Zhang L, Han B. Zhang B, et al. Among authors: chu t. Target Oncol. 2018 Oct;13(5):631-639. doi: 10.1007/s11523-018-0592-z. Target Oncol. 2018. PMID: 30218431 Review.
Adjuvant Chemotherapy Improves Survival in Surgically Resected Stage IB Squamous Lung Cancer.
Xu J, Wang S, Zhong H, Zhang B, Qian J, Yang W, Qian F, Qiao R, Teng J, Lou Y, Zhang X, Chu T, Han B. Xu J, et al. Among authors: chu t. Ann Thorac Surg. 2019 Jun;107(6):1683-1689. doi: 10.1016/j.athoracsur.2018.10.020. Epub 2018 Nov 20. Ann Thorac Surg. 2019. PMID: 30468727
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback